Exome sequencing data and whole genome sequencing data demonstrated that 11% and 18%, respectively, of both HPV+ and HPV- HNSCCs in the general population harbor nonsynonymous mutations in FA genes [57,58], suggesting selective pressure for FA pathway loss during tumor development or progression. This evidence concerns the gene FANCA and neoplasm.